ArticlePeerJ2026
Minilap-assisted modified single-incision
Article in PeerJ, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The single-incision laparoscopic cholecystectomy (SILC) achieves a scarless appearance through a single umbilical approach. However, the restricted surgical field of view, frequent instrument collisions limit its clinical applicability. This study introduces minilap-assisted modified single-incision laparoscopic cholecystectomy (MSILC), incorporating two adjacent trocars at the umbilicus, combined with a 2-mm auxiliary hole created beneath the right costal margin, to mitigate these limitations while preserving aesthetic outcomes. Objective: To explore the clinical value of MSILC compared with traditional SILC (TSILC) in reducing instrument conflict, shortening operation time, improving operator efficiency and cosmetic effects, and providing a basis for the selection of surgical procedures for patients with high body mass index (BMI). Methods: A total of 51 patients with benign gallbladder diseases who underwent MSILC or TSILC between December 2021 and April 2025 at our institution were retrospectively enrolled and categorized into the MSILC ( Results: In the MSILC group, the number of instrument conflicts was reduced by 38.5% (median 16 Conclusion: MSILC significantly improves intraoperative efficiency by optimizing the trocar layout, especially in patients with high BMI, while maintaining safety and cosmetic outcomes comparable with those of TSILC. However, cost increases due to the use of microdevices should be taken into consideration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.